To confirm the role of IL-22 as a pro-inflammatory cytokine in the airway lung inflammation, we evaluated if the levels of this cytokine would be reduced after a mixed allergen-specific and allergen-free immunotherapy. The gene discussed is IL22; the disease is inflammation.